Form 8-K - Current report:
SEC Accession No. 0001144204-19-031045
Filing Date
2019-06-14
Accepted
2019-06-14 17:20:48
Documents
2
Period of Report
2019-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv523618_8k.htm 8-K 20651
2 EXHIBIT 10.1 tv523618_ex10-1.htm EX-10.1 18811
  Complete submission text file 0001144204-19-031045.txt   40772
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37759 | Film No.: 19899795
SIC: 2836 Biological Products, (No Diagnostic Substances)